These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8251053)

  • 1. Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease.
    Miller TP; Tinklenberg JR; Brooks JO; Fenn HH; Yesavage JA
    J Geriatr Psychiatry Neurol; 1993; 6(4):235-8. PubMed ID: 8251053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive decline in Alzheimer's disease: elaborating on the nature of the longitudinal factor structure of the Mini-Mental State Examination.
    Brooks JO; Yesavage JA; Taylor J; Friedman L; Tanke ED; Luby V; Tinklenberg J
    Int Psychogeriatr; 1993; 5(2):135-46. PubMed ID: 8292767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Top cited papers in International Psychogeriatrics: 6c. Tracking cognitive decline in Alzheimer's disease using the Mini-mental State Examination: a meta-analysis ("mini" is not necessarily trivial!).
    Han L
    Int Psychogeriatr; 2009 Dec; 21(6):1037-40. PubMed ID: 19747422
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral and psychological symptoms of dementia in relation to level of cognitive impairment.
    Lövheim H; Sandman PO; Karlsson S; Gustafson Y
    Int Psychogeriatr; 2008 Aug; 20(4):777-89. PubMed ID: 18416871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In Alzheimer's disease, the clinical expression of behavioral and psychological signs and symptoms is early and specific of neuropathological stages].
    Michel BF; Luciani V; Geda YE; Sambuchi N; Paban V; Azorin JM
    Encephale; 2010 Sep; 36(4):314-25. PubMed ID: 20850603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of the Mini-Mental State Examination to the International Classification of Functioning, Disability and Health terminology and scoring system.
    De Vriendt P; Gorus E; Bautmans I; Mets T
    Gerontology; 2012; 58(2):112-9. PubMed ID: 22067433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in the mini-mental state exam in Alzheimer's disease over 2 years: the experience of a dementia clinic.
    McCarten JR; Rottunda SJ; Kuskowski MA
    J Alzheimers Dis; 2004 Feb; 6(1):11-5. PubMed ID: 15004323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis testing of a change point during cognitive decline among Alzheimer's disease patients.
    Ji M; Xiong C; Grundman M
    J Alzheimers Dis; 2003 Oct; 5(5):375-82. PubMed ID: 14646028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the sensitivity of the Alzheimer's Disease Assessment Scale be increased?
    Mattes JA
    Am J Geriatr Psychiatry; 1997; 5(3):258-60. PubMed ID: 9209568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age.
    Wilson RS; Gilley DW; Bennett DA; Beckett LA; Evans DA
    Psychol Aging; 2000 Mar; 15(1):18-28. PubMed ID: 10755286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.
    Chui HC; Lyness SA; Sobel E; Schneider LS
    Arch Neurol; 1994 Jul; 51(7):676-81. PubMed ID: 8018040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative symptoms in Alzheimer's disease: a confirmatory factor analysis.
    de Jonghe JF; Goedhart AW; Ooms ME; Kat MG; Kalisvaart KJ; van Ewijk WM; Ribbe MW
    Int J Geriatr Psychiatry; 2003 Aug; 18(8):748-53. PubMed ID: 12891644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relations among caregiver stress, "sundowning" symptoms, and cognitive decline in Alzheimer's disease.
    Gallagher-Thompson D; Brooks JO; Bliwise D; Leader J; Yesavage JA
    J Am Geriatr Soc; 1992 Aug; 40(8):807-10. PubMed ID: 1634724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.
    Levy ML; Cummings JL; Fairbanks LA; Bravi D; Calvani M; Carta A
    Am J Psychiatry; 1996 Nov; 153(11):1438-43. PubMed ID: 8890677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Mini-Mental State Examination score in Alzheimer's disease patients after stopping habitual drinking.
    Toda A; Tagata Y; Nakada T; Komatsu M; Shibata N; Arai H
    Psychogeriatrics; 2013 Jun; 13(2):94-8. PubMed ID: 23909966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instability of cognitive asymmetry in Alzheimer's disease.
    Xeno Rasmusson D; Brandt J
    J Clin Exp Neuropsychol; 1995 May; 17(3):449-58. PubMed ID: 7650106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.